Moreover, knocking down OAZ1 expression conferred the decrease in sensitivity to cisplatin and increase in cell migration capability in cisplatin-resistant NSCLC cells, indicating that OAZ1 plays a tumor-suppressor role in NSCLC. Here, OAZ1 is linked to neoplasm.